Impact of Telemedicine on Retention in Medications for Opioid Use Disorder (MOUD) Treatment with Buprenorphine in the Times of COVID-19 Pandemic: A Retrospective Chart Review

View Resource

Study examining treatment retention for medication for opioid use disorder (MOUD) patients via telehealth during the COVID-19 pandemic, based on electronic health records of patients at a rural Federally Qualified Health Center (FQHC) in Pennsylvania. Discusses the impacts of telemedicine on retention rates, COVID-19-related challenges to treatment delivery systems, and policy measures to support telehealth and MOUD interventions.

Jagdeep Kaur, Irakli Mania, Raghavendra Tirupathi, Lakshmi Polavarapu

Journal of Rural Mental Health, 46(2), 75-81

04/2022

Document

Illicit drug use · Infectious diseases · Policy · Prescription drug misuse · Statistics and data · Telehealth · Pennsylvania